Enanta Pharmaceuticals reported $-33847000 in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 4441M 338M
Acorda Therapeutics ACOR:US $ -15.69M 13.09M
Amgen AMGN:US $ 828M 1301M
Anika Therapeutics ANIK:US $ 9.18M 7.92M
Arrowhead Research ARWR:US $ -31868000 3.64M
AstraZeneca AZN:LN 1.13B 768M
Biocryst Pharmaceuticals BCRX:US $ -29.58M 21.8M
Biogen BIIB:US $ 485.7M 488.2M
Bristol Myers Squibb BMY:US $ 1715M 36M
Clovis Oncology CLVS:US $ -57.58M 0.43M
Enanta Pharmaceuticals ENTA:US $ -33.85M 4.15M
Gilead Sciences GILD:US $ 2246M 644M
GlaxoSmithKline GSK:LN 1.68B 18M
Halozyme Therapeutics HALO:US $ 93.05M 63.27M
Heron Therapeutics HRTX:US $ -60.47M 8.36M
Insmed INSM:US $ -106255000 22.42M
Intercept Pharmaceuticals ICPT:US $ 0.76M 30.11M
IONIS PHARMACEUT IONS:US $ -81.6M 10.38M
Johnson & Johnson JNJ:US $ 6662M 767M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Ligand Pharmaceuticals LGND:US $ 45.74M 45.82M
Marinus Pharmaceuticals MRNS:US $ -23.48M 3.68M
Merk MRK:US $ 1497M 1517M
Neurocrine Biosciences NBIX:US $ 62.8M 31.3M
Novartis NOVN:VX 3.48B 1.06B
Novavax NVAX:US $ -345.83M 137.2M
Pfizer PFE:US $ 5914M 397M
Ptc Therapeutics PTCT:US $ -98.49M 0.34M
Sarepta Therapeutics SRPT:US $ -167.57M 15.71M
Vertex Pharmaceuticals VRTX:US $ -37.96M 925.79M
Vital Therapies VTL:US $ -19.17M 13.22M
YTE INCY:US $ 140.84M 42.04M